Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric Cancer
Conditions: Gastric Adenocarcinoma; Gastric Cancer; Microbiome; Cytokines; Nutritional Status Interventions: Dietary Supplement: Formulation with probiotics; Other: Non-intervention for Clinical Outcomes -G5 Sponsors: Universidade Federal do Amazonas Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Probiotic Effect on Gastrointestinal Symptoms (FLORABIOTIC REFUERZO).
Conditions: Probiotic; Gastrointestinal Symptoms; Microbiota Interventions: Dietary Supplement: Probiotic; Dietary Supplement: Placebo Sponsors: Clinica Universidad de Navarra, Universidad de Navarra Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Feasibility, Acceptability, and Effectiveness of an Individualized Plant-based (iPLANT) Diet Plan in Colorectal Cancer: Mixed Method Embedded Design
Conditions: Colorectal Cancer; Nutrition Poor; Gastrointestinal Complication; Quality of Life Interventions: Behavioral: iPLANT diet plan and diet counselling; Behavioral: Usual diet counselling Sponsors: National Cancer Institute, Malaysia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Endocytoscopy of Upper Gastrointestinal Tract in Acute Graft-versus-host Disease: a Pilot Study
Conditions: Endocytoscopy Interventions: Procedure: ECS Group Sponsors: Ruijin Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer
Conditions: Metastatic Colorectal Cancer; Metastatic Gastroesophageal Adenocarcinoma; DPD Deficiency Interventions: Drug: Lonsurf; Drug: Oxaliplatin; Drug: Panitumumab; Drug: Bevacizumab; Drug: Trastuzumab; Drug: Nivolumab Sponsors: UNICANCER; Servier Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers
Conditions: Gastric Cancer; GastroEsophageal Cancer; Gastroesophageal Junction Adenocarcinoma Interventions: Other: MDASI-GI Sponsors: Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
National Multicenter Cohort Study of Robot-Assisted Gastrectomy Versus Laparoscopy in Gastric Cancer
Conditions: Gastric Cancer Interventions: Procedure: Robot-Assisted Gastrectomy; Procedure: Laparoscopic Gastrectomy Sponsors: Dr. Negrin University Hospital Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction ，a Phase II Clinical Study
Conditions: Gastric Cancer; GastroEsophageal Cancer; Adenocarcinoma Interventions: Drug: Sintilimab,nab-paclitaxel and tegio Sponsors: Wu Jun Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
A Study of MGC026 in Participants With Advanced Solid Tumors
Conditions: Advanced Solid Tumor; Advanced Cancer; Metastatic Cancer; Squamous Cell Carcinoma of Head and Neck; Non Small Cell Lung Cancer; Small-cell Lung Cancer; Bladder Cancer; Sarcoma; Endometrial Cancer; Melanoma; Castration Resistant Prostatic Cancer; Cervical Cancer; Colorectal Cancer; Gastric Cancer; Gastro-esophageal Cancer; Pancreas Cancer; Clear Cell Renal Cell Carcinoma; Hepatocellular Carcinoma; Platinum-resistant Ovarian Cancer Interventions: Biological: MGC026 Dose Escalation; Biological: MGC026 Dose for Expansion Sponsors: MacroGenics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Gastroparesis as an Early Sign of Sepsis
Conditions: Gastroparesis and Sepsis Interventions: Other: presence of gastroparesis as an early sign for sepsis (bacteremia)- measurement of gastric residual volume Sponsors: Meir Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Effect of Eccentric Streching vs IASTM of Gastrocnemius and Soleus Muscles in Athletes With Ankle Sprain
Conditions: Ankle Sprains Interventions: Other: eccentric streching; Other: IASTM Sponsors: Riphah International University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Conditions: Biliary Tract Cancer; Breast Cancer; Cervical Cancer; Colon Cancer; Endometrial Cancer; Esophageal Cancer; Gastric Cancer; GastroEsophageal Cancer; Head and Neck Cancer; Hepatocellular Cancer; Non-small Cell Lung Cancer; Pancreatic Cancer; Prostate Cancer; Rectal Cancer; Renal Cancer; Thyroid Cancer Interventions: Drug: MDX2001 Sponsors: ModeX Therapeutics, An OPKO Health Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Tislelizumab Plus Chemotherapy as Postoperative Adjuvant Therapy in Elderly Patients With LA GC/GEJC
Conditions: Gastric Cancer Interventions: Drug: Tislelizumab; Drug: S-1 therapy; Drug: low dose SOX therapy Sponsors: First Affiliated Hospital of Wenzhou Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, HER2-negative, Gastric or Gastroesophageal Junction Adenocarcinoma
Conditions: Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Interventions: Drug: irinotecan; Drug: IBI343; Drug: paclitaxel Sponsors: Innovent Biologics (Suzhou) Co. Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
First-line Apatinib Combined With Tislelizumab and Chemotherapy for Advanced GC
Conditions: Advanced Gastric Adenocarcinoma Interventions: Drug: Apatinib Combined With Tislelizumab and Chemotherapy Sponsors: Renmin Hospital of Wuhan University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
